Article

You have full text access to this OnlineOpen article

Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase

  1. Katja Conrath1,2,
  2. Alice S. Pereira3,
  3. Carlos E. Martins3,
  4. Cristina G. Timóteo3,
  5. Pedro Tavares3,
  6. Silvia Spinelli4,
  7. Joerg Kinne5,
  8. Christophe Flaudrops4,
  9. Christian Cambillau4,
  10. Serge Muyldermans1,2,
  11. Isabel Moura3,
  12. Jose J. G. Moura3,
  13. Mariella Tegoni4,*,
  14. Aline Desmyter4,*

Article first published online: 21 JAN 2009

DOI: 10.1002/pro.69

Issue

Protein Science

Protein Science

Volume 18, Issue 3, pages 619–628, March 2009

Additional Information

How to Cite

Conrath, K., Pereira, A. S., Martins, C. E., Timóteo, C. G., Tavares, P., Spinelli, S., Kinne, J., Flaudrops, C., Cambillau, C., Muyldermans, S., Moura, I., Moura, J. J. G., Tegoni, M. and Desmyter, A. (2009), Camelid nanobodies raised against an integral membrane enzyme, nitric oxide reductase. Protein Science, 18: 619–628. doi: 10.1002/pro.69

Author Information

  1. 1

    Laboratory of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Pleinlaan 2, B-1050 Brussels, Belgium

  2. 2

    Department of Molecular and Cellular Interactions, VIB, Brussels, Belgium

  3. 3

    REQUIMTE, Departamento de Química, Centro de Química Fina e Biotecnologia, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, 2829-516 Caparica, Portugal

  4. 4

    Architecture et Fonction des Macromolécules Biologiques, UMR 6098 CNRS and Universités of Marseille, Marseille, France

  5. 5

    Central Veterinary Research Laboratory, Dubai, United Arab Emirates

*Architecture et Fonction des Macromolécules Biologiques, UMR 6098 CNRS and Universités of Marseille, Marseille, France

Publication History

  1. Issue published online: 23 FEB 2009
  2. Article first published online: 21 JAN 2009
  3. Accepted manuscript online: 21 JAN 2009 12:00AM EST
  4. Manuscript Accepted: 18 DEC 2008
  5. Manuscript Received: 20 OCT 2008

Funded by

  • Marseille Nice Génopole® (EU EMEP programme). Grant Number: LSHG-CT2004-504601
  • Marie-Curie (AST-3D). Grant Number: MEIF-CT-2005-024761
  • Fundação para a Ciência e a Tecnologia. Grant Numbers: SFRH/BD/17840/2004, PDTC/QUI/64638/2006

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (592K)

References

  • 1
    Hamers-Casterman C, Atarhouch T, Muyldermans S, Robinson G, Hamers C, Songa EB, Bendahman N, Hamers R ( 1993) Naturally occurring antibodies devoid of light chains. Nature 363: 446–448.
  • 2
    Muyldermans S, Cambillau C, Wyns L ( 2001) Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains. Trends Biochem Sci 26: 230–235.
  • 3
    Dumoulin M, Last AM, Desmyter A, Decanniere K, Canet D, Larsson G, Spencer A, Archer DB, Sasse J, Muyldermans S, Wyns L, Redfield C, Matagne A, Robinson CV, Dobson CM ( 2003) A camelid antibody fragment inhibits the formation of amyloid fibrils by human lysozyme. Nature 424: 783–788.
  • 4
    Dolk E, van der Vaart M, Lutje Hulsik D, Vriend G, de Haard H, Spinelli S, Cambillau C, Frenken L, Verrips T ( 2005a) Isolation of llama antibody fragments for prevention of dandruff by phage display in shampoo. Appl Environ Microbiol 71: 442–450.
  • 5
    Harrison RA, Hasson SS, Harmsen M, Laing GD, Conrath K, Theakston RD ( 2005) Neutralisation of venom-induced haemorrhage by IgG from camels and llamas immunised with viper venom and also by endogenous, non-IgG components in camelid sera. Toxicon 47: 364–368.
  • 6
    Saerens D, Frederix F, Reekmans G, Conrath K, Jans K, Brys L, Huang L, Bosmans E, Maes G, Borghs G, Muyldermans S ( 2005) Engineering camel single-domain antibodies and immobilization chemistry for human prostate-specific antigen sensing. Anal Chem 77: 7547–7555.
  • 7
    Rothbauer U, Zolghadr K, Muyldermans S, Schepers A, Cardoso MC, Leonhardt H ( 2008) A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins. Mol Cell Proteomics 7: 282–289.
  • 8
    Conrath KE, Lauwereys M, Galleni M, Matagne A, Frere JM, Kinne J, Wyns L, Muyldermans S ( 2001) Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae. Antimicrob Agents Chemother 45: 2807–2812.
  • 9
    Cortez-Retamozo V, Lauwereys M, Hassanzadeh Gh G, Gobert M, Conrath K, Muyldermans S, De Baetselier P, Revets H ( 2002) Efficient tumor targeting by single-domain antibody fragments of camels. Int J Cancer 98: 456–462.
    Direct Link:
  • 10
    Aires da Silva F, Santa-Marta M, Freitas-Vieira A, Mascarenhas P, Barahona I, Moniz-Pereira J, Gabuzda D, Goncalves J ( 2004) Camelized rabbit-derived VH single-domain intrabodies against Vif strongly neutralize HIV-1 infectivity. J Mol Biol 340: 525–542.
  • 11
    Harmsen MM, van Solt CB, van Zijderveld-van Bemmel AM, Niewold TA, van Zijderveld FG ( 2006) Selection and optimization of proteolytically stable llama single-domain antibody fragments for oral immunotherapy. Appl Microbiol Biotechnol 72: 544–551.
  • 12
    Desmyter A, Transue TR, Ghahroudi MA, Thi MH, Poortmans F, Hamers R, Muyldermans S, Wyns L ( 1996) Crystal structure of a camel single-domain VH antibody fragment in complex with lysozyme. Nat Struct Biol 3: 803–811.
  • 13
    Spinelli S, Frenken L, Bourgeois D, de Ron L, Bos W, Verrips T, Anguille C, Cambillau C, Tegoni M ( 1996) The crystal structure of a llama heavy chain variable domain. Nat Struct Biol 3: 752–757.
  • 14
    Decanniere K, Desmyter A, Lauwereys M, Ghahroudi MA, Muyldermans S, Wyns L ( 1999) A single-domain antibody fragment in complex with RNase A: non-canonical loop structures and nanomolar affinity using two CDR loops. Structure 7: 361–370.
  • 15
    Decanniere K, Transue TR, Desmyter A, Maes D, Muyldermans S, Wyns L ( 2001) Degenerate interfaces in antigen-antibody complexes. J Mol Biol 313: 473–478.
  • 16
    Desmyter A, Decanniere K, Muyldermans S, Wyns L ( 2001) Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody. J Biol Chem 276: 26285–26290.
  • 17
    Desmyter A, Spinelli S, Payan F, Lauwereys M, Wyns L, Muyldermans S, Cambillau C ( 2002) Three camelid VHH domains in complex with porcine pancreatic alpha-amylase. Inhibition and versatility of binding topology. J Biol Chem 277: 23645–23650.
  • 18
    Renisio JG, Perez J, Czisch M, Guenneugues M, Bornet O, Frenken L, Cambillau C, Darbon H ( 2002) Solution structure and backbone dynamics of an antigen-free heavy chain variable domain (VHH) from Llama. Proteins 47: 546–555.
    Direct Link:
  • 19
    Loris R, Marianovsky I, Lah J, Laeremans T, Engelberg-Kulka H, Glaser G, Muyldermans S, Wyns L ( 2003) Crystal structure of the intrinsically flexible addiction antidote MazE. J Biol Chem 278: 28252–28257.
  • 20
    Spinelli S, Desmyter A, Frenken L, Verrips T, Tegoni M, Cambillau C ( 2004) Domain swapping of a llama VHH domain builds a crystal-wide beta-sheet structure. FEBS Lett 564: 35–40.
  • 21
    Dolk E, van Vliet C, Perez JM, Vriend G, Darbon H, Ferrat G, Cambillau C, Frenken LG, Verrips T ( 2005) Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen. Proteins 59: 555–564.
    Direct Link:
  • 22
    Spinelli S, Desmyter A, Verrips CT, de Haard HJ, Moineau S, Cambillau C ( 2006) Lactococcal bacteriophage p2 receptor-binding protein structure suggests a common ancestor gene with bacterial and mammalian viruses. Nat Struct Mol Biol 13: 85–89.
  • 23
    Spinelli S, Frenken LG, Hermans P, Verrips T, Brown K, Tegoni M, Cambillau C ( 2000) Camelid heavy-chain variable domains provide efficient combining sites to haptens. Biochemistry 39: 1217–1222.
  • 24
    Spinelli S, Tegoni M, Frenken L, van Vliet C, Cambillau C ( 2001) Lateral recognition of a dye hapten by a llama VHH domain. J Mol Biol 311: 123–129.
  • 25
    Einsle O, Kroneck PM ( 2004) Structural basis of denitrification. Biol Chem 385: 875–883.
  • 26
    Fulop V, Moir JW, Ferguson SJ, Hajdu J ( 1995) The anatomy of a bifunctional enzyme: structural basis for reduction of oxygen to water and synthesis of nitric oxide by cytochrome cd1. Cell 81: 369–377.
  • 27
    Nurizzo D, Cutruzzola F, Arese M, Bourgeois D, Brunori M, Cambillau C, Tegoni M ( 1998) Conformational changes occurring upon reduction and NO binding in nitrite reductase from Pseudomonas aeruginosa. Biochemistry 37: 13987–13996.
  • 28
    Brown K, Djinovic-Carugo K, Haltia T, Cabrito I, Saraste M, Moura JJG, Moura I, Tegoni M, Cambillau C ( 2000) Revisiting the catalytic CuZ cluster of nitrous oxide (N2O) reductase - Evidence of a bridging inorganic sulfur. J Biol Chem 275: 41133–41136.
  • 29
    Bertero MG, Rothery RA, Palak M, Hou C, Lim D, Blasco F, Weiner JH, Strynadka NC ( 2003) Insights into the respiratory electron transfer pathway from the structure of nitrate reductase A. Nat Struct Biol 10: 681–687.
  • 30
    Haltia T, Brown K, Tegoni M, Cambillau C, Saraste M, Mattila K, Djinovic-Carugo K ( 2003) Crystal structure of nitrous oxide reductase from Paracoccus denitrificans at 1.6 angstrom resolution. Biochem J 369: 77–88.
  • 31
    Jormakka M, Richardson D, Byrne B, Iwata S ( 2004) Architecture of NarGH reveals a structural classification of Mo-bisMGD enzymes. Structure 12: 95–104.
  • 32
    Iwata S, Ostermeier C, Ludwig B, Michel H ( 1995) Structure at 2.8 A resolution of cytochrome c oxidase from Paracoccus denitrificans. Nature 376: 660–669.
  • 33
    Forte E, Urbani A, Saraste M, Sarti P, Brunori M, Giuffre A ( 2001) The cytochrome cbb3 from Pseudomonas stutzeri displays nitric oxide reductase activity. Eur J Biochem 268: 6486–6491.
    Direct Link:
  • 34
    Kabat EA, Wu TT, Perry HM, Gottesmann KS, Foeller C ( 1991) in NH Publication no. 91-3242, 5th Ed., U.S. Department of Health and Human Services.
  • 35
    Fan SF, Kao CY ( 1992) Three-dimensional structure of an Fv from a human IgM immunoglobulin. Eur J Pharmacol 229: 259–263.
  • 36
    Hunte C, Michel H ( 2002) Crystallisation of membrane proteins mediated by antibody fragments. Curr Opin Struct Biol 12: 503–508.
  • 37
    Rothlisberger D, Pos KM, Pluckthun A ( 2004) An antibody library for stabilizing and crystallizing membrane proteins selecting binders to the citrate carrier CitS. FEBS Lett 564: 340–348.
  • 38
    Rasmussen SG, Choi HJ, Rosenbaum DM, Kobilka TS, Thian FS, Edwards PC, Burghammer M, Ratnala VR, Sanishvili R, Fischetti RF, Schertler GF, Weis WI, Kobilka BK ( 2007) Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450: 383–387.
  • 39
    Kleymann G, Ostermeier C, Ludwig B, Skerra A, Michel H ( 1995) Engineered Fv fragments as a tool for the one-step purification of integral multisubunit membrane protein complexes. Biotechnology (N Y) 13: 155–160.
  • 40
    Brown K, Nurizzo D, Besson S, Shepard W, Moura J, Moura I, Tegoni M, Cambillau C ( 1999) MAD structure of Pseudomonas nautica dimeric cytochrome c(552) mimicks the c(4) dihemic cytochrome domain association. J Mol Biol 289: 1017–1028.
  • 41
    Thorndycroft FH, Butland G, Richardson DJ, Watmough NJ ( 2007) A new assay for nitric oxide reductase reveals two conserved glutamate residues form the entrance to a proton-conducting channel in the bacterial enzyme. Biochem J 401: 111–119.
  • 42
    Cramm R, Pohlmann A, Friedrich B ( 1999) Purification and characterization of the single-component nitric oxide reductase from Ralstonia eutropha H16. FEBS Lett 460: 6–10.
  • 43
    Prudêncio M, Pereira AS, Tavares P, Besson S, Cabrito I, Brown K, Samyn B, Devreese B, Van Beeumen J, Rusnak F, Fauque G, Moura JJ, Tegoni M, Cambillau C, Moura I. ( 2000) Purification, characterization, and preliminary crystallographic study of copper-containing nitrous oxide reductase from Pseudomonas nautica 617. Biochemistry 39: 3899–3907.
  • 44
    Saerens D, Kinne J, Bosmans E, Wernery U, Muyldermans S, Conrath K ( 2004) Single domain antibodies derived from dromedary lymph node and peripheral blood lymphocytes sensing conformational variants of prostate-specific antigen. J Biol Chem 279: 51965–51972.
  • 45
    Arbabi Ghahroudi M, Desmyter A, Wyns L, Hamers R, Muyldermans S ( 1997) Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett 414: 521–526.
  • 46
    Lauwereys M, Arbabi Ghahroudi M, Desmyter A, Kinne J, Holzer W, De Genst E, Wyns L, Muyldermans S ( 1998) Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO J 17: 3512–3520.
  • 47
    Skerra A, Pluckthun A ( 1988) Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 240: 1038–1041.
View Full Article (HTML) Get PDF (592K)